Related references
Note: Only part of the references are listed.Structural organization of the Golgi apparatus
Martin Lowe
CURRENT OPINION IN CELL BIOLOGY (2011)
LRRK2: A Problem Lurking in Vesicle Trafficking?
Sybille Dihanich et al.
JOURNAL OF NEUROSCIENCE (2011)
LRRK2 Controls Synaptic Vesicle Storage and Mobilization within the Recycling Pool
Giovanni Piccoli et al.
JOURNAL OF NEUROSCIENCE (2011)
Dopaminergic Neuronal Loss, Reduced Neurite Complexity and Autophagic Abnormalities in Transgenic Mice Expressing G2019S Mutant LRRK2
David Ramonet et al.
PLOS ONE (2011)
Prevention of intracellular degradation of I2020T mutant LRRK2 restores its protectivity against apoptosis
Etsuro Ohta et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
LRRK2 Kinase Regulates Synaptic Morphology through Distinct Substrates at the Presynaptic and Postsynaptic Compartments of the Drosophila Neuromuscular Junction
Seongsoo Lee et al.
JOURNAL OF NEUROSCIENCE (2010)
A rotarod test for evaluation of motor skill learning
Hiromi Shiotsuki et al.
JOURNAL OF NEUROSCIENCE METHODS (2010)
Impaired dopaminergic neurotransmission and microtubule-associated protein tau alterations in human LRRK2 transgenic mice
H. L. Melrose et al.
NEUROBIOLOGY OF DISEASE (2010)
A comparative study of Lrrk2 function in primary neuronal cultures
Justus C. Daechsel et al.
PARKINSONISM & RELATED DISORDERS (2010)
I2020T leucine-rich repeat kinase 2, the causative mutant molecule of familial Parkinson's disease, has a higher intracellular degradation rate than the wild-type molecule
Etsuro Ohta et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
LRRK2 in Parkinson's disease: function in cells and neurodegeneration
Philip J. Webber et al.
FEBS JOURNAL (2009)
Leucine-rich repeat kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease
Katerina Venderova et al.
HUMAN MOLECULAR GENETICS (2009)
Emerging role of LRRK2 in human neural progenitor cell cycle progression, survival and differentiation
Javorina Milosevic et al.
MOLECULAR NEURODEGENERATION (2009)
Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
Yanping Li et al.
NATURE NEUROSCIENCE (2009)
Leucine-Rich Repeat Kinase 2 Regulates the Progression of Neuropathology Induced by Parkinson's-Disease-Related Mutant α-synuclein
Xian Lin et al.
NEURON (2009)
Familial parkinsonism: Study of original Sagamihara PARK8 (I2020T) kindred with variable clinicopathologic outcomes
Kazuko Hasegawa et al.
PARKINSONISM & RELATED DISORDERS (2009)
R1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice
Youren Tong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila
Yuzuru Imai et al.
EMBO JOURNAL (2008)
LRRK2 regulates synaptic vesicle endocytosis
Narae Shin et al.
EXPERIMENTAL CELL RESEARCH (2008)
Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice
K. S. Rommelfanger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
LRRK2 phosphorylates moesin at threonine-558: characterization of how Parkinson's disease mutants affect kinase activity
Mahaboobi Jaleel et al.
BIOCHEMICAL JOURNAL (2007)
LRK-1, a C-elegans PARK8-Related kinase, regulates axonal-dendritic polarity of SV proteins
Aisa Sakaguchi-Nakashima et al.
CURRENT BIOLOGY (2007)
Fragmentation of the Golgi apparatus: An early apoptotic event independent of the cytoskeleton
Shaeri Mukherjee et al.
TRAFFIC (2007)
Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease
Haydn N. Allbutt et al.
JOURNAL OF NEUROSCIENCE METHODS (2007)
Impairment of microtubule-dependent trafficking by overexpression of α-synuclein
He-Jin Lee et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Localization of LRRK2 to membranous and vesicular structures in mammalian brain
Saskia Biskup et al.
ANNALS OF NEUROLOGY (2006)
Fragmentation of Golgi apparatus of nigral neurons with α-synuclein-positive inclusions in patients with Parkinson's disease
Yukio Fujita et al.
ACTA NEUROPATHOLOGICA (2006)
Fragmentation of the Golgi apparatus in neurodegenerative diseases and cell death
Nicholas K. Gonatas et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family
M Funayama et al.
ANNALS OF NEUROLOGY (2005)
Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal doparnine in a pre-symptomatic stage model of Parkinson's disease
T Ogura et al.
NEUROSCIENCE RESEARCH (2005)
The RIP kinases: crucial integrators of cellular stress
E Meylan et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Early and progressive sensorimotor anomalies in mice overexpressing wild-type human α-synuclein
SM Fleming et al.
JOURNAL OF NEUROSCIENCE (2004)
Somatostatin receptor 2 knockout/lacZ knockin mice show impaired motor coordination and reveal sites of somatostatin action within the striatum
JP Allen et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Golgi fragmentation occurs in the cells with prefibrillar α-synuclein aggregates and precedes the formation of fibrillar inclusion
N Gosavi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1
M Funayama et al.
ANNALS OF NEUROLOGY (2002)
Share Paper
